NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Sun Communities, Inc. (NYSE:SUI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sun-communities-inc-lawsuit-submission-form?prid=125687&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=125685&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Robbins LLPreminds investors that a class action was filed against Sun Communities, Inc. (NYSE: SUI) for wrongdoing between February 28, 2019 and September 24, 2024. Sun Communities is a real estate investment company that focuses its investments on manufactured housing communities, recreational vehicle communities, and marinas. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg For more information, submit a form, emailattorney Aaron

Creates leading global driveline and metal forming supplier with comprehensive product portfolio and diversified customer base Combination will have expanded and balanced geographic presence across multiple automotive segments supporting ICE, Hybrid and Electric powertrains; expected to generate annual revenues of approximately $12 billion on a non-adjusted combined basis Expected to deliver approximately $300 million annual

Robbins LLPreminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.

“For the full year 2024, net sales amounted toSEK 526.8 billion (552.3) and the adjusted operating income to SEK 65.7 billion (78.2), with an adjusted operating margin of 12.5% (14.0). Return on capital employed in the Industrial Operations was strong at 35.8% (36.7). We also generated a strong operating cash flow of SEK 45.3 billion

LONDON, UNITED KINGDOM / ACCESS Newswire / January 29, 2025 / Helium One Global (AIM:HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development project in Colorado, USA, acknowledges the Blue Star Helium (ASX:BNL) ("Blue Star") announcement issued today regarding the Galactica-Pegasus project in Las Animas County, Colorado,

LONDON, UNITED KINGDOM / ACCESS Newswire / January 29, 2025 / Ecora Resources PLC (LSE:ECOR)(TSX: ECOR) issues the following trading update for the period 1 October to 31 December 2024. Fourth Quarter and Full Year 2024 Portfolio Contribution Increased production volumes at Voisey’s Bay and Mantos Blancos underpinned a portfolio contribution of US$6.7m in Q4

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform Findings in lung cancer show that CTCs can provide additional biomarkers not found in ctDNA from single blood sample ANGLE invited to present data at EACR-Illumina webinar on 6 February 2025 GUILDFORD, SURREY / ACCESS Newswire / January 29, 2025

(CNSX:NXT.CN),(Boerse Frankfurt – Freiverkehr:Z12.F), Fredericton, New Brunswick, Jan. 28, 2025 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (FSE:Z12) (“NextGen” or the “Company“) is pleased to announce, due to significant market demand and further to its news release on January 10, 2025 and January 23, 2025, that it has increased the size of its previously